Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 97 articles:
HTML format
Text format



Single Articles


    May 2018
  1. SPRIGG N, Flaherty K, Appleton JP, Salman RA, et al
    Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Lancet. 2018 May 15. pii: S0140-6736(18)31033.
    PubMed     Text format     Abstract available


    February 2018
  2. ABUKARESH A, Al-Abadlah R, Bottcher B, El-Essi K, et al
    Ischaemic stroke management at Al-Shifa Hospital in the Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S7.
    PubMed     Text format     Abstract available


  3. ALKHATIB MN, Abd-Alghafoor T, Elmassry A, Albarqouni L, et al
    Management of acute ischaemic stroke at Nasser Hospital, Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S28.
    PubMed     Text format     Abstract available


  4. THE LANCET
    Stroke-acting FAST at all ages.
    Lancet. 2018;391:514.
    PubMed     Text format    


    December 2017
  5. AMARENCO P
    Learning from TARDIS: time for more focused trials in stroke prevention.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)33309.
    PubMed     Text format    


  6. BATH PM, Woodhouse LJ, Appleton JP, Beridze M, et al
    Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)32849.
    PubMed     Text format     Abstract available


    August 2017
  7. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32155.
    PubMed     Text format     Abstract available


  8. JINATONGTHAI P, Kongwatcharapong J, Foo CY, Phrommintikul A, et al
    Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Lancet. 2017;390:747-759.
    PubMed     Text format     Abstract available


    July 2017
  9. SAKAMOTO R, Higuchi A, Tsuda K, Tanimoto T, et al
    Intensive speech and language therapy after stroke.
    Lancet. 2017;390:228.
    PubMed     Text format    


  10. BREITENSTEIN C, Martus P, Willmes K, Ziegler W, et al
    Intensive speech and language therapy after stroke - Authors' reply.
    Lancet. 2017;390:228-229.
    PubMed     Text format    


  11. WARE RE, de Montalembert M, Tshilolo L, Abboud MR, et al
    Sickle cell disease.
    Lancet. 2017;390:311-323.
    PubMed     Text format     Abstract available


    June 2017

  12. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial.
    Lancet. 2017 Jun 27. pii: S0140-6736(17)31447.
    PubMed     Text format     Abstract available


  13. LI L, Geraghty OC, Mehta Z, Rothwell PM, et al
    Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Lancet. 2017 Jun 13. pii: S0140-6736(17)30770.
    PubMed     Text format     Abstract available


    April 2017
  14. HACHINSKI V
    Stoop to conquer: preventing stroke and dementia together.
    Lancet. 2017;389:1518.
    PubMed     Text format    


    March 2017
  15. HEALEY JS, Oldgren J
    Risk of mortality and stroke after atrial fibrillation - Authors' reply.
    Lancet. 2017;389:907.
    PubMed     Text format    


  16. HUO Z
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:907.
    PubMed     Text format    


  17. MIHAS C, Mariolis A, Letsas KP, Kantzanou M, et al
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:906.
    PubMed     Text format    


    February 2017
  18. BREITENSTEIN C, Grewe T, Floel A, Ziegler W, et al
    Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
    Lancet. 2017 Feb 27. pii: S0140-6736(17)30067.
    PubMed     Text format     Abstract available


    January 2017
  19. HANLEY DF, Lane K, McBee N, Ziai W, et al
    Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
    Lancet. 2017 Jan 9. pii: S0140-6736(16)32410.
    PubMed     Text format     Abstract available


  20. RABINSTEIN AA
    Intracerebral haemorrhage: no good treatment but treatment helps.
    Lancet. 2017 Jan 9. pii: S0140-6736(17)30002.
    PubMed     Text format    


  21. O'DONNELL M, Yusuf S
    The INTERSTROKE study on risk factors for stroke - Authors' reply.
    Lancet. 2017;389:36.
    PubMed     Text format    


  22. ZENG X, Deng A, Ding Y
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35.
    PubMed     Text format    


    November 2016
  23. COLLINS R, Reith C, Emberson J, Armitage J, et al
    Interpretation of the evidence for the efficacy and safety of statin therapy.
    Lancet. 2016;388:2532-2561.
    PubMed     Text format     Abstract available


    October 2016
  24. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available


  25. CHARIDIMOU A
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979.
    PubMed     Text format    


  26. PROVIDENCIA R, Lambiase PD
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979-1980.
    PubMed     Text format    


  27. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available


  28. SHAKIR R, Davis S, Norrving B, Grisold W, et al
    Revising the ICD: stroke is a brain disease.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31850.
    PubMed     Text format    


    September 2016
  29. HANKEY GJ
    Stroke.
    Lancet. 2016 Sep 13. pii: S0140-6736(16)30962.
    PubMed     Text format     Abstract available


    August 2016
  30. GOETTE A, Merino JL, Ezekowitz MD, Zamoryakhin D, et al
    Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31474.
    PubMed     Text format     Abstract available


  31. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    PubMed     Text format     Abstract available


  32. BAGOT KL, Cadilhac DA, Hand PJ, Vu M, et al
    Telemedicine expedites access to optimal acute stroke care.
    Lancet. 2016;388:757-758.
    PubMed     Text format    


  33. THE LANCET
    Atrial fibrillation and stroke: unrecognised and undertreated.
    Lancet. 2016;388:731.
    PubMed     Text format    


  34. PICCINI JP, Fauchier L
    Rhythm control in atrial fibrillation.
    Lancet. 2016;388:829-840.
    PubMed     Text format     Abstract available


  35. FREEDMAN B, Potpara TS, Lip GY
    Stroke prevention in atrial fibrillation.
    Lancet. 2016;388:806-817.
    PubMed     Text format     Abstract available


  36. HEALEY JS, Oldgren J, Ezekowitz M, Zhu J, et al
    Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
    Lancet. 2016 Aug 8. pii: S0140-6736(16)30968.
    PubMed     Text format     Abstract available


  37. BORLONGAN CV
    Age of PISCES: stem-cell clinical trials in stroke.
    Lancet. 2016 Aug 3. pii: S0140-6736(16)31259.
    PubMed     Text format    


  38. KALLADKA D, Sinden J, Pollock K, Haig C, et al
    Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.
    Lancet. 2016 Aug 3. pii: S0140-6736(16)30513.
    PubMed     Text format     Abstract available


    July 2016
  39. SNYDER A
    Philip Majerus.
    Lancet. 2016;388:458.
    PubMed     Text format    


  40. FEIGIN VL, Krishnamurthi R
    Stroke is largely preventable across the globe: where to next?
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30679.
    PubMed     Text format    


  41. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available


  42. BLACK N
    Is hospital mortality higher at weekends? If so, why?
    Lancet. 2016;388:108-11.
    PubMed     Text format    


    May 2016
  43. ROTHWELL PM, Algra A, Chen Z, Diener HC, et al
    Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Lancet. 2016 May 18. pii: S0140-6736(16)30468.
    PubMed     Text format     Abstract available


  44. HANKEY GJ
    The benefits of aspirin in early secondary stroke prevention.
    Lancet. 2016 May 18. pii: S0140-6736(16)30511.
    PubMed     Text format    


  45. BRAY BD, Cloud GC, James MA, Hemingway H, et al
    Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care.
    Lancet. 2016 May 10. pii: S0140-6736(16)30443.
    PubMed     Text format     Abstract available


  46. BAHAROGLU MI, Cordonnier C, Salman RA, de Gans K, et al
    Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Lancet. 2016 May 9. pii: S0140-6736(16)30392.
    PubMed     Text format     Abstract available


  47. PRODAN CI
    Platelets after intracerebral haemorrhage: more is not better.
    Lancet. 2016 May 9. pii: S0140-6736(16)30478.
    PubMed     Text format    


  48. SANDERCOCK P, Wardlaw J, Lindley R, Whiteley W, et al
    IST-3 stroke trial data available.
    Lancet. 2016;387:1904.
    PubMed     Text format    


    April 2016
  49. HIJAZI Z, Oldgren J, Lindback J, Alexander JH, et al
    The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)00741.
    PubMed     Text format     Abstract available


    March 2016
  50. NAYLOR AR
    Age and carotid intervention outcomes.
    Lancet. 2016;387:1255-7.
    PubMed     Text format    


    February 2016
  51. MUIR KW, White P
    HERMES: messenger for stroke interventional treatment.
    Lancet. 2016 Feb 18. pii: S0140-6736(16)00351.
    PubMed     Text format    


  52. GOYAL M, Menon BK, van Zwam WH, Dippel DW, et al
    Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
    Lancet. 2016 Feb 18. pii: S0140-6736(16)00163.
    PubMed     Text format     Abstract available


  53. WARE RE, Davis BR, Schultz WH, Brown RC, et al
    Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
    Lancet. 2016;387:661-70.
    PubMed     Text format     Abstract available


  54. HOWARD G, Roubin GS, Jansen O, Hendrikse J, et al
    Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials.
    Lancet. 2016 Feb 12. pii: S0140-6736(15)01309.
    PubMed     Text format     Abstract available


    January 2016
  55. KALRA L
    Prophylactic antibiotics to reduce pneumonia after acute stroke - Author's reply.
    Lancet. 2016;387:433.
    PubMed     Text format    


  56. NEUGEBAUER H, Lindner-Pfleghar B, Juttler E, Ludolph AC, et al
    Prophylactic antibiotics to reduce pneumonia after acute stroke.
    Lancet. 2016;387:432-3.
    PubMed     Text format    


  57. MILOSEVIC I, Dale A, Drysdale H, Mahtani K, et al
    Prophylactic antibiotics to reduce pneumonia after acute stroke.
    Lancet. 2016;387:432.
    PubMed     Text format    


  58. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Lancet. 2016 Jan 12. pii: S0140-6736(15)01166.
    PubMed     Text format     Abstract available


  59. FROBERT O, James SK
    Coronary thrombus aspiration: a lesson for clinical medicine.
    Lancet. 2016;387:97-8.
    PubMed     Text format    


    December 2015

  60. Postacute stroke care: same standards as acute care?
    Lancet. 2015;386:2366.
    PubMed     Text format    


    November 2015
  61. XIE X, Atkins E, Lv J, Bennett A, et al
    Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Lancet. 2015 Nov 7. pii: S0140-6736(15)00805.
    PubMed     Text format     Abstract available


    October 2015
  62. VERHEUGT FW, Granger CB
    Intracerebral haemorrhage, atrial fibrillation, and anticoagulation - Authors' reply.
    Lancet. 2015;386:1737.
    PubMed     Text format    


  63. WILSON D, Al-Shahi Salman R, Klijn CJ, Lip GY, et al
    Intracerebral haemorrhage, atrial fibrillation, and anticoagulation.
    Lancet. 2015;386:1736-7.
    PubMed     Text format    


  64. BERNHARDT J
    Could upright posture be harmful in the early stages of stroke? - Author's reply.
    Lancet. 2015;386:1734-5.
    PubMed     Text format    


  65. BARER D, Watkins C
    Could upright posture be harmful in the early stages of stroke?
    Lancet. 2015;386:1734.
    PubMed     Text format    


  66. JOLLY SS, Cairns JA, Yusuf S, Rokoss MJ, et al
    Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00448.
    PubMed     Text format     Abstract available


  67. WEISZ G, Genereux P, Iniguez A, Zurakowski A, et al
    Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00459.
    PubMed     Text format     Abstract available


    September 2015
  68. KALRA L, Irshad S, Hodsoll J, Simpson M, et al
    Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.
    Lancet. 2015 Sep 3. pii: S0140-6736(15)00126.
    PubMed     Text format     Abstract available


  69. MEISEL A, Smith CJ
    Prevention of stroke-associated pneumonia: where next?
    Lancet. 2015 Sep 3. pii: S0140-6736(15)00127.
    PubMed     Text format    


    August 2015
  70. KIVIMAKI M, Jokela M, Nyberg ST, Singh-Manoux A, et al
    Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals.
    Lancet. 2015 Aug 19. pii: S0140-6736(15)60295.
    PubMed     Text format     Abstract available


  71. JANLERT U
    Long working hours: an avoidable cause of stroke?
    Lancet. 2015 Aug 19. pii: S0140-6736(15)61000.
    PubMed     Text format    


  72. BUCHAN AM, Karbalai HG, Sutherland BA
    The future of stroke therapy must not be mired by past arguments.
    Lancet. 2015;386:654.
    PubMed     Text format    


  73. VAN DE BEEK D, Brouwer M, Nederkoorn P
    Parenteral antibiotics are not enough to prevent pneumonia in stroke - Authors' reply.
    Lancet. 2015;386:653-4.
    PubMed     Text format    


  74. SILVESTRI L, van Saene HK, Milanese M, Ros S, et al
    Parenteral antibiotics are not enough to prevent pneumonia in stroke.
    Lancet. 2015;386:653.
    PubMed     Text format    


    June 2015
  75. HILL AM, McPhail SM, Waldron N, Etherton-Beer C, et al
    Fall rates in hospital rehabilitation units after individualised patient and staff education programmes: a pragmatic, stepped-wedge, cluster-randomised controlled trial.
    Lancet. 2015;385:2592-9.
    PubMed     Text format     Abstract available


  76. RUFF CT, Giugliano RP, Braunwald E, Morrow DA, et al
    Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
    Lancet. 2015;385:2288-95.
    PubMed     Text format     Abstract available


  77. MEGA JL, Walker JR, Ruff CT, Vandell AG, et al
    Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
    Lancet. 2015;385:2280-7.
    PubMed     Text format     Abstract available


    May 2015
  78. ROTHWELL PM
    AVERT: a major milestone in stroke research.
    Lancet. 2015 May 8. pii: S0140-6736(15)60906.
    PubMed     Text format    


  79. SCHNABEL RB, Yin X, Gona P, Larson MG, et al
    50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.
    Lancet. 2015 May 7. pii: S0140-6736(14)61774.
    PubMed     Text format     Abstract available


    April 2015

  80. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.
    Lancet. 2015 Apr 16. pii: S0140-6736(15)60690.
    PubMed     Text format     Abstract available


  81. EMBERSON J, Lees KR, Lyden P, Baigent C, et al
    Thrombolysis in acute stroke--authors' reply.
    Lancet. 2015;385:1396.
    PubMed     Text format    


  82. CASO V, Michel P
    Thrombolysis in acute stroke.
    Lancet. 2015;385:1395-6.
    PubMed     Text format    


  83. NEWMAN DH
    Thrombolysis in acute stroke.
    Lancet. 2015;385:1395.
    PubMed     Text format    


  84. APPELROS P, Terent A
    Thrombolysis in acute stroke.
    Lancet. 2015;385:1394.
    PubMed     Text format    


  85. BRUNSTROM M, Carlberg B
    Thrombolysis in acute stroke.
    Lancet. 2015;385:1394-5.
    PubMed     Text format    



  86. Thrombolysis for stroke: clinical judgment at its apogee.
    Lancet. 2015;385:1366.
    PubMed     Text format    


  87. FULCHER J, O'Connell R, Voysey M, Emberson J, et al
    Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
    Lancet. 2015;385:1397-405.
    PubMed     Text format     Abstract available


  88. JEONG HG, Koo DL, Nam H, Kwon HM, et al
    Reversible right heart failure after medullary stroke.
    Lancet. 2015;385:1364.
    PubMed     Text format    


    March 2015
  89. KAPADIA SR, Leon MB, Makkar RR, Tuzcu EM, et al
    5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
    Lancet. 2015 Mar 13. pii: S0140-6736(15)60290.
    PubMed     Text format     Abstract available


  90. VERHEUGT FW, Granger CB
    Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.
    Lancet. 2015 Mar 11. pii: S0140-6736(15)60245.
    PubMed     Text format     Abstract available


  91. ZANNAD F, Cannon CP, Cushman WC, Bakris GL, et al
    Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
    Lancet. 2015 Mar 9. pii: S0140-6736(14)62225.
    PubMed     Text format     Abstract available


  92. WASHAM JB, Stevens SR, Lokhnygina Y, Halperin JL, et al
    Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tria
    Lancet. 2015 Mar 5. pii: S0140-6736(14)61836.
    PubMed     Text format     Abstract available


    February 2015
  93. BONATI LH, Dobson J, Featherstone RL, Ederle J, et al
    Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial.
    Lancet. 2015;385:529-38.
    PubMed     Text format     Abstract available


    January 2015
  94. MEISEL A
    Preventive antibiotic therapy in stroke: PASSed away?
    Lancet. 2015 Jan 19. pii: S0140-6736(15)60076.
    PubMed     Text format    


  95. WESTENDORP WF, Vermeij JD, Zock E, Hooijenga IJ, et al
    The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.
    Lancet. 2015 Jan 19. pii: S0140-6736(14)62456.
    PubMed     Text format     Abstract available


    October 2014
  96. ROTHWELL PM
    Blood pressure in acute stroke: which questions remain?
    Lancet. 2014 Oct 21. pii: S0140-6736(14)61898.
    PubMed     Text format    



  97. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.
    Lancet. 2014 Oct 21. pii: S0140-6736(14)61121.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: